EurekaMag.com logo
+ Site Statistics
References:
52,725,316
Abstracts:
28,411,598
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on Google+Follow on Google+
Follow on LinkedInFollow on LinkedIn

+ Translate

Gene farms - a new way of producing biologically active proteins using transgenic animals






Sel' skokhozyaistvennaya Biologiya (6): 3-27

Gene farms - a new way of producing biologically active proteins using transgenic animals

The production of recombinant proteins by microorganisms, cultured cells and transgenic animals is reviewed.


Accession: 002549391



Related references

Brem, G.; Zinov'eva, N.; Ernst, L., 1993: Gene farms is a new way for producing biologically active proteins by transgenic animals. Various systems of producing recombinant proteins (microorganisms eucariotic cultures, transgenic animals) are considered. Methods of transfering gene constructions the; most often used are described. The programme for making transgenic mammals is...

Lakhtin, V.M.; Afanas'ev, S.S.; Vorob'ev, A.A.; Aleshkin, V.A.; NesvizhskiÄ­, I.V.; Lakhtin, M.V., 2006: New generation pharmaceuticals from milk of transgenic animals. The problem of isolation of biologically active proteins. The authors of the review characterize the protein components of milk and adduce data on the expression of transgenic proteins in animal milk. Technological principles of purification of recombinant medicinal proteins from milk of transgenic anim...

Gordon K.; Pittius C.W.; Vitale J.; Lee E.; Nicols E.; Westphal H.; Hennighausen L., 1988: Expression of biologically active human tpa in the milk transgenic animals. Abstracts of Papers American Chemical Society 196: MBTD 55

Castro, F.O.idio; Limonta, J.; Rodriguez, A.; Aguirre, A.; D.L.F.ente, J.; Aguilar, A.; Ramos, B.; Hayes, O., 1999: Transgenic rabbits for the production of biologically-active recombinant proteins in the milk. The use of live bioreactors for the expression of human genes in the mammary gland of transgenic animals is one of the most cost-effective ways for the production of valuable recombinant therapeutic proteins. Among the transgenic species used so f...

Larrick, J.W.; Thomas, D.W., 2000: Producing proteins in transgenic plants and animals. The most recent advances in technologies involved in recombinant protein production in transgenic plants and animals are reviewed. Therapeutic advances using these plant- and animal-produced proteins are discussed. Some issues on the hazards of us...

Larrick, J.W.; Thomas, D.W., 2001: Producing proteins in transgenic plants and animals. The requirement for large quantities of therapeutic proteins has fueled interest in the production of recombinant proteins in plants and animals. The first commercial products to be made in this way have experienced much success, and it is predict...

Bosze, Z.; Hiripi, L.; Carnwath, J.W.; Niemann, H., 2003: The transgenic rabbit as model for human diseases and as a source of biologically active recombinant proteins. Until recently, transgenic rabbits were produced exclusively by pronuclear microinjection which results in additive random insertional transgenesis; however, progress in somatic cell cloning based on nuclear transfer will soon make it possible to...

Wondisford, F.E.; Weintraub, B.D., 2001: Biologically active synthetic thyrotropin and cloned gene for producing same. Substantially pure recombinant TSH has been prepared from a clone comprising complete nucleotide sequence for the expression of the TSH. Diagnostic and therapeutic applications of the synthetic TSH are described.

Wondisford, F.E.; Weintraub, B.D., 2000: Biologically active synthetic thyrotropin and cloned gene producing same. Substantially pure recombinant TSH has been prepared from a clone comprising complete nucleotide sequence for the expression of the TSH. Diagnostic and therapeutic applications of the synthetic TSH are described.

Iaroslavov, A.A.; Kaplan, I.V.; Erokhina, T.N.; Morozov, S.Iu.; Solov'ev, A.G.; Leshchiner, A.D.; Riakhnianskaia, A.A.; Malinin, A.C.; Stepanova, L.A.; Kiselev, O.I.; Atabekov, I.G., 2011: A new method of producing biologically active nanocomplexes by non-covalent conjugation of proteins with viral particles. Currently, a range of biologically active molecules have been attached to plant and bacterial viras nanoscaffolds, yielding stable nanoparticles that display multiple copies of the desired molecule. In this paper we propose a new method of non-cov...